Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Marion De Jong
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Living Beings
Concepts & Ideas
Disorders
Anatomy
Sign-in to see full Profile
Network (preview)
124
Krenning, Eric
57
Breeman, Wouter
41
Bernard, Bert
41
Visser, Theo
37
Bakker, Willem
33
Kwekkeboom, Dik
27
Valkema, Roelf
24
Hennemann, Georg
23
Docter, Roel
23
Kooij, Peter
19
Rolleman, Edgar
17
Srinivasan, Ananth
16
Erion, Jack
12
Forrer, Flavio
11
Melis, Marleen
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Marion De Jong (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Fröberg Alida C; de Jong Marion; Nock Berthold A; Breeman Wout A P; Erion Jack L; Maina Theodosia; Verdijsseldonck Marion; de Herder Wouter W; van der Lugt Aad; Kooij Peter P M; Krenning Eric P
Comparison of three radiolabelled peptide analogues for CCK-2 receptor scintigraphy in medullary thyroid carcinoma.
European journal of nuclear medicine and molecular imaging 2009;36(8):1265-72.
-
2009: Yim Cheng-Bin; Boerman Otto C; de Visser Monique; de Jong Marion; Dechesne Annemarie C; Rijkers Dirk T S; Liskamp Rob M J
Versatile conjugation of octreotide to dendrimers by cycloaddition ("click") chemistry to yield high-affinity multivalent cyclic Peptide dendrimers.
Bioconjugate chemistry 2009;20(7):1323-31.
-
2009: van Essen Martijn; Krenning Eric P; Kam Boen L R; de Jong Marion; Valkema Roelf; Kwekkeboom Dik J
Peptide-receptor radionuclide therapy for endocrine tumors.
Nature reviews. Endocrinology 2009;5(7):382-93.
-
2009: de Jong Marion; Breeman Wout A P; Kwekkeboom Dik J; Valkema Roelf; Krenning Eric P
Tumor imaging and therapy using radiolabeled somatostatin analogues.
Accounts of chemical research 2009;42(7):873-80.
-
2009: Forrer Flavio; Krenning Eric P; Kooij Peter P; Bernard Bert F; Konijnenberg Mark; Bakker Willem H; Teunissen Jaap J M; de Jong Marion; van Lom Kirsten; de Herder Wouter W; Kwekkeboom Dik J
Bone marrow dosimetry in peptide receptor radionuclide therapy with [177Lu-DOTA(0),Tyr(3)]octreotate.
European journal of nuclear medicine and molecular imaging 2009;36(7):1138-46.
-
2008: Breeman Wouter A P; Fröberg A C; de Blois E; van Gameren A; Melis M; de Jong M; Maina T; Nock B A; Erion J L; Mäcke H R; Krenning E P
Optimised labeling, preclinical and initial clinical aspects of CCK-2 receptor-targeting with 3 radiolabeled peptides.
Nuclear medicine and biology 2008;35(8):839-49.
-
2008: Kouch-el Filali Mariam; Kilic Emine; Melis Marleen; de Klein Annelies; de Jong Marion; Luyten Gregorius P M
Expression of the SST receptor 2 in uveal melanoma is not a prognostic marker.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie 2008;246(11):1585-92.
-
2008: Vegt Erik; van Eerd Julliëtte E M; Eek Annemarie; Oyen Wim J G; Wetzels Jack F M; de Jong Marion; Russel Frans G M; Masereeuw Rosalinde; Gotthardt Martin; Boerman Otto C
Reducing renal uptake of radiolabeled peptides using albumin fragments.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(9):1506-11.
-
2008: de Visser Monique; Verwijnen Suzanne M; de Jong Marion
Update: improvement strategies for peptide receptor scintigraphy and radionuclide therapy.
Cancer biotherapy & radiopharmaceuticals 2008;23(2):137-57.
-
2008: Müller Cristina; Schibli Roger; Krenning Eric P; de Jong Marion
Pemetrexed improves tumor selectivity of 111In-DTPA-folate in mice with folate receptor-positive ovarian cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(4):623-9.
-
2008: Müller Cristina; Forrer Flavio; Schibli Roger; Krenning Eric P; de Jong Marion
SPECT study of folate receptor-positive malignant and normal tissues in mice using a novel 99mTc-radiofolate.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(2):310-7.
-
2008: Laverman Peter; Roosenburg Susan; Gotthardt Martin; Park Jeseong; Oyen Wim J G; de Jong Marion; Hellmich Mark R; Rutjes Floris P J T; van Delft Floris L; Boerman Otto C
Targeting of a CCK(2) receptor splice variant with (111)In-labelled cholecystokinin-8 (CCK8) and (111)In-labelled minigastrin.
European journal of nuclear medicine and molecular imaging 2008;35(2):386-92.
-
2008: Rolleman E J; Bernard B F; Breeman W A P; Forrer F; de Blois E; Hoppin J; Gotthardt M; Boerman O C; Krenning E P; de Jong M
Molecular imaging of reduced renal uptake of radiolabelled [DOTA0,Tyr3]octreotate by the combination of lysine and Gelofusine in rats.
Nuklearmedizin. Nuclear medicine 2008;47(3):110-5.
-
2007: Melis M; Forrer F; Capello A; Bijster M; Bernard B F; Reubi J C; Krenning E P; De Jong M
Up-regulation of somatostatin receptor density on rat CA20948 tumors escaped from low dose [177Lu-DOTA0,Tyr3]octreotate therapy.
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutical Chemistry and Biology 2007;51(4):324-33.
-
2007: Horst Maarten ter; Brouwer Eric; Verwijnen Suzanne; Rodijk Mark; de Jong Marion; Hoeben Rob; de Leeuw Bertie; Smitt Peter Sillevis
Targeting malignant gliomas with a glial fibrillary acidic protein (GFAP)-selective oncolytic adenovirus.
The journal of gene medicine 2007;9(12):1071-9.
-
2007: Rolleman Edgar J; Kooij Peter P M; de Herder Wouter W; Valkema Roelf; Krenning Eric P; de Jong Marion
Somatostatin receptor subtype 2-mediated uptake of radiolabelled somatostatin analogues in the human kidney.
European journal of nuclear medicine and molecular imaging 2007;34(11):1854-60.
-
2007: Melis Marleen; Krenning Eric P; Bernard Bert F; de Visser Monique; Rolleman Edgar; de Jong Marion
Renal uptake and retention of radiolabeled somatostatin, bombesin, neurotensin, minigastrin and CCK analogues: species and gender differences.
Nuclear medicine and biology 2007;34(6):633-41.
-
2007: Müller Cristina; Schibli Roger; Forrer Flavio; Krenning Eric P; de Jong Marion
Dose-dependent effects of (anti)folate preinjection on 99mTc-radiofolate uptake in tumors and kidneys.
Nuclear medicine and biology 2007;34(6):603-8.
-
2007: de Visser M; Bernard H F; Erion J L; Schmidt M A; Srinivasan A; Waser B; Reubi J C; Krenning E P; de Jong M
Novel 111In-labelled bombesin analogues for molecular imaging of prostate tumours.
European journal of nuclear medicine and molecular imaging 2007;34(8):1228-38.
-
2007: Forrer F; Rolleman E; Schramm N; Krenning E P; de Jong M
Is it possible to predict renal function in small animals using a multi-pinhole SPECT system.
European journal of nuclear medicine and molecular imaging 2007;34(7):1127-8.
-
2007: Janssen Paul J J M; de Visser Moniaue; Verwijnen Suzanne M; Bernard Bert F; Srinivasan Ananth; Erion Jack L; Breeman Wouter A P; Vulto Arnold G; Krenning Eric P; de Jong Marion
Five Stabilized 111In-labeled neurotensin analogs in nude mice bearing HT29 tumors.
Cancer biotherapy & radiopharmaceuticals 2007;22(3):374-81.
-
2007: Breeman W A P; Kwekkeboom D J; de Blois E; de Jong M; Visser T J; Krenning E P
Radiolabelled regulatory peptides for imaging and therapy.
Anti-cancer agents in medicinal chemistry 2007;7(3):345-57.
-
2007: Biddlecombe Gráinne B; Rogers Buck E; de Visser Monique; Parry Jesse J; de Jong Marion; Erion Jack L; Lewis Jason S
Molecular imaging of gastrin-releasing peptide receptor-positive tumors in mice using 64Cu- and 86Y-DOTA-(Pro1,Tyr4)-bombesin(1-14).
Bioconjugate chemistry 2007;18(3):724-30.
-
2007: Rolleman Edgar J; Forrer Flavio; Bernard Bert; Bijster Magda; Vermeij Marcel; Valkema Roelf; Krenning Eric P; de Jong Marion
Amifostine protects rat kidneys during peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotate.
European journal of nuclear medicine and molecular imaging 2007;34(5):763-71.
-
2007: Gotthardt Martin; van Eerd-Vismale Julliëtte; Oyen Wim J G; de Jong Marion; Zhang Hanwen; Rolleman Edgar; Maecke Helmut R; Béhé Martin; Boerman Otto
Indication for different mechanisms of kidney uptake of radiolabeled peptides.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(4):596-601.
-
2007: Forrer Flavio; Valkema Roelf; Kwekkeboom Dik J; de Jong Marion; Krenning Eric P
Neuroendocrine tumors. Peptide receptor radionuclide therapy.
Best practice & research. Clinical endocrinology & metabolism 2007;21(1):111-29.
-
2007: Müller Cristina; Forrer Flavio; Bernard Bert F; Melis Marleen; Konijnenberg Mark; Krenning Eric P; de Jong Marion
Diagnostic versus therapeutic doses of [(177)Lu-DOTA-Tyr(3)]-octreotate: uptake and dosimetry in somatostatin receptor-positive tumors and normal organs.
Cancer biotherapy & radiopharmaceuticals 2007;22(1):151-9.
-
2007: Forrer Flavio; Rolleman Edgar; Bijster Magda; Melis Marleen; Bernard Bert; Krenning Eric P; de Jong Marion
From outside to inside? Dose-dependent renal tubular damage after high-dose peptide receptor radionuclide therapy in rats measured with in vivo (99m)Tc-DMSA-SPECT and molecular imaging.
Cancer biotherapy & radiopharmaceuticals 2007;22(1):40-9.
-
2007: Rolleman Edgar J; Krenning Eric P; Bernard Bert F; de Visser Monique; Bijster Magda; Visser Theo J; Vermeij Marcel; Lindemans Jan; de Jong Marion
Long-term toxicity of [(177)Lu-DOTA (0),Tyr (3)]octreotate in rats.
European journal of nuclear medicine and molecular imaging 2007;34(2):219-27.
-
2007: Konijnenberg Mark; Melis Marleen; Valkema Roelf; Krenning Eric; de Jong Marion
Radiation dose distribution in human kidneys by octreotides in peptide receptor radionuclide therapy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(1):134-42.
-
2007: de Visser Monique; van Weerden Wytske M; de Ridder Corrina M A; Reneman Suzanne; Melis Marleen; Krenning Eric P; de Jong Marion
Androgen-dependent expression of the gastrin-releasing peptide receptor in human prostate tumor xenografts.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(1):88-93.
-
2007: Rolleman Edgar J; Forrer Flavio; Deckers Jaap; de Groot Hans; Valkema Roelf; de Jong Marion; Krenning Eric P
Anaphylactoid reaction from amifostine.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2007;82(1):110-1; author reply 111.
-
2007: Van Essen Martijn; Krenning Eric P; De Jong Marion; Valkema Roelf; Kwekkeboom Dik J
Peptide Receptor Radionuclide Therapy with radiolabelled somatostatin analogues in patients with somatostatin receptor positive tumours.
Acta oncologica (Stockholm, Sweden) 2007;46(6):723-34.
-
2006: Rolleman Edgar J; de Jong Marion; Valkema Roelf; Kwekkeboom Dik; Kam Boen; Krenning Eric P
Inhibition of kidney uptake of radiolabeled somatostatin analogs: amino acids or gelofusine?
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(10):1730-1; author reply 1731.
-
2006: Forrer F; Valkema R; Bernard B; Schramm N U; Hoppin J W; Rolleman E; Krenning E P; de Jong M
In vivo radionuclide uptake quantification using a multi-pinhole SPECT system to predict renal function in small animals.
European journal of nuclear medicine and molecular imaging 2006;33(10):1214-7.
-
2006: ter Horst Maarten; Verwijnen Suzanne M; Brouwer Eric; Hoeben Rob C; de Jong Marion; de Leeuw Bertie H C G M; Sillevis Smitt Peter A E
Locoregional delivery of adenoviral vectors.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(9):1483-9.
-
2006: Maina Theodosia; Nock Berthold A; Cordopatis Paul; Bernard Bert F; Breeman Wout A P; van Gameren Arthur; van den Berg Ria; Reubi Jean-Claude; Krenning Eric P; de Jong Marion
[(99m)Tc]Demotate 2 in the detection of sst(2)-positive tumours: a preclinical comparison with [(111)In]DOTA-tate.
European journal of nuclear medicine and molecular imaging 2006;33(7):831-40.
-
2006: Rolleman Edgar J; Valkema Roelf; Melis Marleen; de Jong Marion; Krenning Eric P; Visser Theo J; Rolleman Edgar J
Cubilin and megalin in radiation-induced renal injury with labelled somatostatin analogues: are we just dealing with the kidney?
European journal of nuclear medicine and molecular imaging 2006;33(6):749-50.
-
2006: Capello Astrid; Krenning Eric P; Bernard Bert F; Breeman Wout A P; Erion Jack L; de Jong Marion
Anticancer activity of targeted proapoptotic peptides.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(1):122-9.
-
2005: Verwijnen Suzanne M; Krenning Eric P; Valkema Roelf; Huijmans Jan G M; de Jong Marion
Oral versus intravenous administration of lysine: equal effectiveness in reduction of renal uptake of [111In-DTPA]octreotide.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(12):2057-60.
-
2005: Walrand Stephan; Jamar François; de Jong Marion; Pauwels Stanislas
Evaluation of novel whole-body high-resolution rodent SPECT (Linoview) based on direct acquisition of linogram projections.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(11):1872-80.
-
2005: Capello Astrid; Krenning Eric; Bernard Bert; Reubi Jean-Claude; Breeman Wout; de Jong Marion
111In-labelled somatostatin analogues in a rat tumour model: somatostatin receptor status and effects of peptide receptor radionuclide therapy.
European journal of nuclear medicine and molecular imaging 2005;32(11):1288-95.
-
2005: de Jong Marion; Barone Raffaella; Krenning Eric; Bernard Bert; Melis Marleen; Visser Theo; Gekle Michael; Willnow Thomas E; Walrand Stephan; Jamar François; Pauwels Stanislas
Megalin is essential for renal proximal tubule reabsorption of (111)In-DTPA-octreotide.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(10):1696-700.
-
2005: Melis Marleen; Krenning Eric P; Bernard Bert F; Barone Raffaella; Visser Theo J; de Jong Marion
Localisation and mechanism of renal retention of radiolabelled somatostatin analogues.
European journal of nuclear medicine and molecular imaging 2005;32(10):1136-43.
-
2005: Teunissen Jaap J M; Kwekkeboom Dik J; de Jong Marion; Esser Jan-Paul; Valkema Roelf; Krenning Eric P
Endocrine tumours of the gastrointestinal tract. Peptide receptor radionuclide therapy.
Best practice & research. Clinical gastroenterology 2005;19(4):595-616.
-
2005: Breeman Wouter A P; de Jong Marion; de Blois Erik; Bernard Bert F; Konijnenberg Mark; Krenning Eric P
Radiolabelling DOTA-peptides with 68Ga.
European journal of nuclear medicine and molecular imaging 2005;32(4):478-85.
-
2005: Hofland Leo J; Capello Astrid; Krenning Eric P; de Jong Marion; van Hagen Martin P
Induction of apoptosis with hybrids of Arg-Gly-Asp molecules and peptides and antimitotic effects of hybrids of cytostatic drugs and peptides.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46 Suppl 1():191S-8S.
-
2005: Valkema Roelf; Pauwels Stanislas A; Kvols Larry K; Kwekkeboom Dik J; Jamar Francois; de Jong Marion; Barone Raffaella; Walrand Stephan; Kooij Peter P M; Bakker Willem H; Lasher Janet; Krenning Eric P
Long-term follow-up of renal function after peptide receptor radiation therapy with (90)Y-DOTA(0),Tyr(3)-octreotide and (177)Lu-DOTA(0), Tyr(3)-octreotate.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46 Suppl 1():83S-91S.
-
2005: Krenning Eric P; Valkema Roelf; Kwekkeboom Dik J; de Herder Wouter W; van Eijck Casper H J; de Jong Marion; Pauwels Stanislas; Reubi Jean-Claude
Molecular imaging as in vivo molecular pathology for gastroenteropancreatic neuroendocrine tumors: implications for follow-up after therapy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46 Suppl 1():76S-82S.
-
2005: de Jong Marion; Breeman Wout A P; Valkema Roelf; Bernard Bert F; Krenning Eric P
Combination radionuclide therapy using 177Lu- and 90Y-labeled somatostatin analogs.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46 Suppl 1():13S-7S.
-
2004: Capello Astrid; Krenning Eric P; Bernard Bert F; Breeman Wout A P; van Hagen Martin P; de Jong Marion
Increased cell death after therapy with an Arg-Gly-Asp-linked somatostatin analog.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(10):1716-20.
-
2004: Breeman Wouter A P; De Jong Maarten Th M; De Blois Erik; Bernard Bert F; De Jong Marion; Krenning Eric P
Reduction of skeletal accumulation of radioactivity by co-injection of DTPA in [90Y-DOTA0,Tyr3]octreotide solutions containing free 90Y3+.
Nuclear medicine and biology 2004;31(6):821-4.
-
2004: Konijnenberg Mark W; Bijster Magda; Krenning Eric P; De Jong Marion
A stylized computational model of the rat for organ dosimetry in support of preclinical evaluations of peptide receptor radionuclide therapy with (90)Y, (111)In, or (177)Lu.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(7):1260-9.
-
2004: De Jong Marion; Valkema Roelf; Van Gameren Arthur; Van Boven Hester; Bex Axel; Van De Weyer Eric Pieter; Burggraaf Jan Dirk; Körner Meike; Reubi Jean-Claude; Krenning Eric P
Inhomogeneous localization of radioactivity in the human kidney after injection of [(111)In-DTPA]octreotide.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(7):1168-71.
-
2004: Verwijnen Suzanne; Capello Astrid; Bernard Bert; van den Aardweg Gerard; Konijnenberg Mark; Breeman Wout; Krenning Eric; de Jong Marion
Low-dose-rate irradiation by 131I versus high-dose-rate external-beam irradiation in the rat pancreatic tumor cell line CA20948.
Cancer biotherapy & radiopharmaceuticals 2004;19(3):285-92.
-
2004: Bernard Bert; Capello Astrid; van Hagen Martin; Breeman Wout; Srinivasan Ananth; Schmidt Michelle; Erion Jack; van Gameren Arthur; Krenning Eric; de Jong Marion
Radiolabeled RGD-DTPA-Tyr3-octreotate for receptor-targeted radionuclide therapy.
Cancer biotherapy & radiopharmaceuticals 2004;19(2):173-80.
-
2004: Krenning Eric P; Kwekkeboom Dik J; Valkema Roelf; Pauwels Stanislas; Kvols Larry K; De Jong Marion
Peptide receptor radionuclide therapy.
Annals of the New York Academy of Sciences 2004;1014():234-45.
-
2004: Rolleman Edgar J; Krenning Eric P; Van Gameren Arthur; Bernard Bert F; De Jong Marion
Uptake of [111In-DTPA0]octreotide in the rat kidney is inhibited by colchicine and not by fructose.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(4):709-13.
-
2004: Verwijnen Suzanne M; Sillevis Smith Peter A E; Hoeben Rob C; Rabelink Martin J W E; Wiebe Leonard; Curiel David T; Hemminki Akseli; Krenning Eric P; de Jong Marion
Molecular imaging and treatment of malignant gliomas following adenoviral transfer of the herpes simplex virus-thymidine kinase gene and the somatostatin receptor subtype 2 gene.
Cancer biotherapy & radiopharmaceuticals 2004;19(1):111-20.
-
2003: Capello Astrid; Krenning Eric P; Breeman Wout A P; Bernard Bert F; Konijnenberg Mark W; de Jong Marion
Tyr3-octreotide and Tyr3-octreotate radiolabeled with 177Lu or 90Y: peptide receptor radionuclide therapy results in vitro.
Cancer biotherapy & radiopharmaceuticals 2003;18(5):761-8.
-
2003: de Visser M; Janssen P J J M; Srinivasan A; Reubi J C; Waser B; Erion J L; Schmidt M A; Krenning E P; de Jong M
Stabilised 111In-labelled DTPA- and DOTA-conjugated neurotensin analogues for imaging and therapy of exocrine pancreatic cancer.
European journal of nuclear medicine and molecular imaging 2003;30(8):1134-9.
-
2003: Breeman Wouter A P; De Jong Marion; Visser Theo J; Erion Jack L; Krenning Eric P
Optimising conditions for radiolabelling of DOTA-peptides with 90Y, 111In and 177Lu at high specific activities.
European journal of nuclear medicine and molecular imaging 2003;30(6):917-20.
-
2003: Breeman Wouter A P; Mearadji Amir; Capello Astrid; Bernard Bert F; van Eijck Casper H J; Krenning Eric P; de Jong Marion
Anti-tumor effect and increased survival after treatment with [177Lu-DOTA0,Tyr3]octreotate in a rat liver micrometastases model.
International journal of cancer. Journal international du cancer 2003;104(3):376-9.
-
2003: Kwekkeboom D J; Bakker W H; Kam B L; Teunissen J J M; Kooij P P M; de Herder W W; Feelders R A; van Eijck C H J; de Jong M; Srinivasan A; Erion J L; Krenning E P
Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [177Lu-DOTA(0),Tyr3]octreotate.
European journal of nuclear medicine and molecular imaging 2003;30(3):417-22.
-
2003: de Jong Marion; Kwekkeboom Dik; Valkema Roelf; Krenning Eric P
Radiolabelled peptides for tumour therapy: current status and future directions. Plenary lecture at the EANM 2002.
European journal of nuclear medicine and molecular imaging 2003;30(3):463-9.
-
2003: Breeman Wouter A P; van der Wansem Katy; Bernard Bert F; van Gameren Arthur; Erion Jack L; Visser Theo J; Krenning Eric P; de Jong M
The addition of DTPA to [177Lu-DOTA0,Tyr3]octreotate prior to administration reduces rat skeleton uptake of radioactivity.
European journal of nuclear medicine and molecular imaging 2003;30(2):312-5.
-
2003: Capello Astrid; Krenning Eric P; Breeman Wout A P; Bernard Bert F; de Jong Marion
Peptide receptor radionuclide therapy in vitro using [111In-DTPA0]octreotide.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(1):98-104.
-
2003: Rolleman Edgar J; Valkema Roelf; de Jong Marion; Kooij Peter P M; Krenning Eric P
Safe and effective inhibition of renal uptake of radiolabelled octreotide by a combination of lysine and arginine.
European journal of nuclear medicine and molecular imaging 2003;30(1):9-15.
-
2002: Breeman Wouter A P; de Jong Marion; Erion Jack L; Bugaj Joseph E; Srinivasan Ananth; Bernard Bert F; Kwekkeboom Dik J; Visser Theo J; Krenning Eric P
Preclinical comparison of (111)In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy and radionuclide therapy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2002;43(12):1650-6.
-
2002: Nanda Dharmin; de Jong Marion; Vogels Ronald; Havenga Menzo; Driesse Maarten; Bakker Willem; Bijster Magda; Avezaat Cees; Cox Peter; Morin Kevin; Naimi Ebrahim; Knaus Edward; Wiebe Leonard; Smitt Peter Sillevis
Imaging expression of adenoviral HSV1-tk suicide gene transfer using the nucleoside analogue FIRU.
European journal of nuclear medicine and molecular imaging 2002;29(7):939-47.
-
2002: de Jong Marion; Krenning Eric
New advances in peptide receptor radionuclide therapy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2002;43(5):617-20.
-
2002: De Jong Marion; Valkema Roelf; Jamar Francois; Kvols Larry K; Kwekkeboom Dik J; Breeman Wout A P; Bakker Willem H; Smith Chuck; Pauwels Stanislas; Krenning Eric P
Somatostatin receptor-targeted radionuclide therapy of tumors: preclinical and clinical findings.
Seminars in nuclear medicine 2002;32(2):133-40.
-
2002: Valkema Roelf; De Jong Marion; Bakker Willem H; Breeman Wout A p; Kooij Peter P m; Lugtenburg Pieternella J; De Jong Frank H; Christiansen Arjan; Kam Boen L r; De Herder Wouter W; Stridsberg Mats; Lindemans Jan; Ensing Geert; Krenning Eric P
Phase I study of peptide receptor radionuclide therapy with [In-DTPA]octreotide: the Rotterdam experience.
Seminars in nuclear medicine 2002;32(2):110-22.
-
2001: de Jong M; Breeman W A; Bernard B F; Bakker W H; Visser T J; Kooij P P; van Gameren A; Krenning E P
Tumor response after [(90)Y-DOTA(0),Tyr(3)]octreotide radionuclide therapy in a transplantable rat tumor model is dependent on tumor size.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001;42(12):1841-6.
-
2001: Breeman W A; de Jong M; Kwekkeboom D J; Valkema R; Bakker W H; Kooij P P; Visser T J; Krenning E P
Somatostatin receptor-mediated imaging and therapy: basic science, current knowledge, limitations and future perspectives.
European journal of nuclear medicine 2001;28(9):1421-9.
-
2001: Kwekkeboom D J; Bakker W H; Kooij P P; Konijnenberg M W; Srinivasan A; Erion J L; Schmidt M A; Bugaj J L; de Jong M; Krenning E P
[177Lu-DOTAOTyr3]octreotate: comparison with [111In-DTPAo]octreotide in patients.
European journal of nuclear medicine 2001;28(9):1319-25.
-
2001: de Jong M; Breeman W A; Bernard B F; Bakker W H; Schaar M; van Gameren A; Bugaj J E; Erion J; Schmidt M; Srinivasan A; Krenning E P
[177Lu-DOTA(0),Tyr3] octreotate for somatostatin receptor-targeted radionuclide therapy.
International journal of cancer. Journal international du cancer 2001;92(5):628-33.
-
2001: Slooter G D; Mearadji A; Breeman W A; Marquet R L; de Jong M; Krenning E P; van Eijck C H
Somatostatin receptor imaging, therapy and new strategies in patients with neuroendocrine tumours.
The British journal of surgery 2001;88(1):31-40.
-
2000: Bernard B F; Krenning E; Breeman W A; Visser T J; Bakker W H; Srinivasan A; de Jong M
Use of the rat pancreatic CA20948 cell line for the comparison of radiolabelled peptides for receptor-targeted scintigraphy and radionuclide therapy.
Nuclear medicine communications 2000;21(11):1079-85.
-
2000: Kwekkeboom D; Krenning E P; de Jong M
Peptide receptor imaging and therapy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2000;41(10):1704-13.
-
2000: Kwekkeboom D J; Bakker W H; Kooij P P; Erion J; Srinivasan A; de Jong M; Reubi J C; Krenning E P
Cholecystokinin receptor imaging using an octapeptide DTPA-CCK analogue in patients with medullary thyroid carcinoma.
European journal of nuclear medicine 2000;27(9):1312-7.
-
2000: van Hagen P M; Breeman W A; Bernard H F; Schaar M; Mooij C M; Srinivasan A; Schmidt M A; Krenning E P; de Jong M
Evaluation of a radiolabelled cyclic DTPA-RGD analogue for tumour imaging and radionuclide therapy.
International journal of cancer. Journal international du cancer 2000;90(4):186-98.
-
2000: Krenning E P; de Jong M
Therapeutic use of radiolabelled peptides.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11 Suppl 3():267-71.
-
2000: Krenning E P; Valkema R; Kooij P P; Breeman W A; Bakker W H; de Herder W W; van Eijck C H; Kwekkeboom D J; de Jong M; Jamar F; Pauwels S
The role of radioactive somatostatin and its analogues in the control of tumor growth.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 2000;153():1-13.
-
1999: De Jong M; Breeman W A; Bernard H F; Kooij P P; Slooter G D; Van Eijck C H; Kwekkeboom D J; Valkema R; Mäcke H R; Krenning E P
Therapy of neuroendocrine tumors with radiolabeled somatostatin-analogues.
The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) 1999;43(4):356-66.
-
1999: de Jong M; Bakker W H; Bernard B F; Valkema R; Kwekkeboom D J; Reubi J C; Srinivasan A; Schmidt M; Krenning E P
Preclinical and initial clinical evaluation of 111In-labeled nonsulfated CCK8 analog: a peptide for CCK-B receptor-targeted scintigraphy and radionuclide therapy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(12):2081-7.
-
1999: Breeman W A; De Jong M; Bernard B F; Kwekkeboom D J; Srinivasan A; van der Pluijm M E; Hofland L J; Visser T J; Krenning E P
Pre-clinical evaluation of [(111)In-DTPA-Pro(1), Tyr(4)]bombesin, a new radioligand for bombesin-receptor scintigraphy.
International journal of cancer. Journal international du cancer 1999;83(5):657-63.
-
1999: de Jong M; Breeman W A; Bernard B F; van Gameren A; de Bruin E; Bakker W H; van der Pluijm M E; Visser T J; Mäcke H R; Krenning E P
Tumour uptake of the radiolabelled somatostatin analogue [DOTA0, TYR3]octreotide is dependent on the peptide amount.
European journal of nuclear medicine 1999;26(7):693-8.
-
1999: Breeman W A; Hofland L J; de Jong M; Bernard B F; Srinivasan A; Kwekkeboom D J; Visser T J; Krenning E P
Evaluation of radiolabelled bombesin analogues for receptor-targeted scintigraphy and radiotherapy.
International journal of cancer. Journal international du cancer 1999;81(4):658-65.
-
1999: Hofland L J; Breeman W A; Krenning E P; de Jong M; Waaijers M; van Koetsveld P M; Mäcke H R; Lamberts S W
Internalization of [DOTA degrees,125I-Tyr3]Octreotide by somatostatin receptor-positive cells in vitro and in vivo: implications for somatostatin receptor-targeted radio-guided surgery.
Proceedings of the Association of American Physicians 1999;111(1):63-9.
-
1999: van Eijck C H; de Jong M; Breeman W A; Slooter G D; Marquet R L; Krenning E P
Somatostatin receptor imaging and therapy of pancreatic endocrine tumors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10 Suppl 4():177-81.
-
1999: Krenning E P; de Jong M; Kooij P P; Breeman W A; Bakker W H; de Herder W W; van Eijck C H; Kwekkeboom D J; Jamar F; Pauwels S; Valkema R
Radiolabelled somatostatin analogue(s) for peptide receptor scintigraphy and radionuclide therapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10 Suppl 2():S23-9.
-
1998: Bernard B F; Krenning E P; Breeman W A; Ensing G; Benjamins H; Bakker W H; Visser T J; de Jong M
99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-Q12 in vitro and in vivo.
Nuclear medicine and biology 1998;25(3):233-40.
-
1998: De Jong M; Bernard B F; De Bruin E; Van Gameren A; Bakker W H; Visser T J; Mäcke H R; Krenning E P
Internalization of radiolabelled [DTPA0]octreotide and [DOTA0,Tyr3]octreotide: peptides for somatostatin receptor-targeted scintigraphy and radionuclide therapy.
Nuclear medicine communications 1998;19(3):283-8.
-
1998: de Jong M; Breeman W A; Bakker W H; Kooij P P; Bernard B F; Hofland L J; Visser T J; Srinivasan A; Schmidt M A; Erion J L; Bugaj J E; Mäcke H R; Krenning E P
Comparison of (111)In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy.
Cancer research 1998;58(3):437-41.
-
1998: Breeman W A; de Jong M; Bernard B; Hofland L J; Srinivasan A; van der Pluijm M; Bakker W H; Visser T J; Krenning E P
Tissue distribution and metabolism of radioiodinated DTPA0, D-Tyr1 and Tyr3 derivatives of octreotide in rats.
Anticancer research 1998;18(1A):83-9.
-
1998: De Jong M; Bakker W H; Breeman W A; Bernard B F; Hofland L J; Visser T J; Srinivasan A; Schmidt M; Béhé M; Mäcke H R; Krenning E P
Pre-clinical comparison of [DTPA0] octreotide, [DTPA0,Tyr3] octreotide and [DOTA0,Tyr3] octreotide as carriers for somatostatin receptor-targeted scintigraphy and radionuclide therapy.
International journal of cancer. Journal international du cancer 1998;75(3):406-11.
-
1997: Bernard B F; Krenning E P; Breeman W A; Rolleman E J; Bakker W H; Visser T J; Mäcke H; de Jong M
D-lysine reduction of indium-111 octreotide and yttrium-90 octreotide renal uptake.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(12):1929-33.
-
1997: Breeman W A; de Jong M; Bernard B F; Bakker W H; Rolleman E J; Kwekkeboom D J; Visser T J; Krenning E P
Effects of ligand priming and multiple-dose injection on tissue uptake of 111In-pentetreotide in rats.
Nuclear medicine and biology 1997;24(8):749-53.
-
1997: de Jong M; Bakker W H; Krenning E P; Breeman W A; van der Pluijm M E; Bernard B F; Visser T J; Jermann E; Béhé M; Powell P; Mäcke H R
Yttrium-90 and indium-111 labelling, receptor binding and biodistribution of [DOTA0,d-Phe1,Tyr3]octreotide, a promising somatostatin analogue for radionuclide therapy.
European journal of nuclear medicine 1997;24(4):368-71.
-
1996: de Jong M; Bernard B F; Breeman W A; Ensing G; Benjamins H; Bakker W H; Visser T J; Krenning E P
Comparison of uptake of 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-Q12 into human breast cancer cell lines.
European journal of nuclear medicine 1996;23(10):1361-6.
-
1996: Breeman W A; Bakker W H; De Jong M; Hofland L J; Kwekkeboom D J; Kooij P P; Visser T J; Krenning E P
Studies on radiolabeled somatostatin analogues in rats and in patients.
The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) 1996;40(3):209-20.
-
1996: Everts M E; de Jong M; Lim C F; Docter R; Krenning E P; Visser T J; Hennemann G
Different regulation of thyroid hormone transport in liver and pituitary: its possible role in the maintenance of low T3 production during nonthyroidal illness and fasting in man.
Thyroid : official journal of the American Thyroid Association 1996;6(4):359-68.
-
1996: de Jong M; Rolleman E J; Bernard B F; Visser T J; Bakker W H; Breeman W A; Krenning E P
Inhibition of renal uptake of indium-111-DTPA-octreotide in vivo.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(8):1388-92.
-
1996: Bakker W H; Breeman W A; van der Pluijm M E; de Jong M; Visser T J; Krenning E P
Iodine-131 labelled octreotide: not an option for somatostatin receptor therapy.
European journal of nuclear medicine 1996;23(7):775-81.
-
1996: van Stralen P G; van der Hoek H J; Docter R; de Jong M; Krenning E P; Everts M E; Hennemann G
Uptake and metabolism of 3,5,3'-triiodothyronine and 3,3',5'-triiodothyronine by human liver-derived cells: HepG2 cells as a model for thyroid hormone handling by human liver.
The Journal of clinical endocrinology and metabolism 1996;81(1):244-8.
-
1995: Everts M E; Visser T J; Moerings E P; Tempelaars A M; van Toor H; Docter R; de Jong M; Krenning E P; Hennemann G
Uptake of 3,3',5,5'-tetraiodothyroacetic acid and 3,3',5'-triiodothyronine in cultured rat anterior pituitary cells and their effects on thyrotropin secretion.
Endocrinology 1995;136(10):4454-61.
-
1995: Vos R A; De Jong M; Bernard B F; Docter R; Krenning E P; Hennemann G
Impaired thyroxine and 3,5,3'-triiodothyronine handling by rat hepatocytes in the presence of serum of patients with nonthyroidal illness.
The Journal of clinical endocrinology and metabolism 1995;80(8):2364-70.
-
1995: de Jong M; Breeman W A; Bernard B F; Rolleman E J; Hofland L J; Visser T J; Setyono-Han B; Bakker W H; van der Pluijm M E; Krenning E P
Evaluation in vitro and in rats of 161Tb-DTPA-octreotide, a somatostatin analogue with potential for intraoperative scanning and radiotherapy.
European journal of nuclear medicine 1995;22(7):608-16.
-
1995: Everts M E; Lim C F; Moerings E P; Docter R; Visser T J; De Jong M; Krenning E P; Hennemann G
Effects of a furan fatty acid and indoxyl sulfate on thyroid hormone uptake in cultured anterior pituitary cells.
The American journal of physiology 1995;268(5 Pt 1):E974-9.
-
1994: Everts M E; Visser T J; Moerings E P; Docter R; van Toor H; Tempelaars A M; de Jong M; Krenning E P; Hennemann G
Uptake of triiodothyroacetic acid and its effect on thyrotropin secretion in cultured anterior pituitary cells.
Endocrinology 1994;135(6):2700-7.
-
1994: de Jong M; Docter R; van der Hoek H; Krenning E P; Hennemann G
Adaptive changes in transmembrane transport and metabolism of triiodothyronine in perfused livers of fed and fasted hypothyroid and hyperthyroid rats.
Metabolism: clinical and experimental 1994;43(11):1355-61.
-
1994: Krenning E P; Kwekkeboom D J; de Jong M; Visser T J; Reubi J C; Bakker W H; Kooij P P; Lamberts S W
Essentials of peptide receptor scintigraphy with emphasis on the somatostatin analog octreotide.
Seminars in oncology 1994;21(5 Suppl 13):6-14.
-
1994: Everts M E; Visser T J; van Buuren J C; Docter R; de Jong M; Krenning E P; Hennemann G
Uptake of triiodothyronine sulfate and suppression of thyrotropin secretion in cultured anterior pituitary cells.
Metabolism: clinical and experimental 1994;43(10):1282-6.
-
1994: Krenning E P; Kooij P P; Bakker W H; Breeman W A; Postema P T; Kwekkeboom D J; Oei H Y; de Jong M; Visser T J; Reijs A E
Radiotherapy with a radiolabeled somatostatin analogue, [111In-DTPA-D-Phe1]-octreotide. A case history.
Annals of the New York Academy of Sciences 1994;733():496-506.
-
1994: Everts M E; Docter R; Moerings E P; van Koetsveld P M; Visser T J; de Jong M; Krenning E P; Hennemann G
Uptake of thyroxine in cultured anterior pituitary cells of euthyroid rats.
Endocrinology 1994;134(6):2490-7.
-
1994: De Jong M; Docter R; Bernard B F; van der Heijden J T; van Toor H; Krenning E P; Hennemann G
T4 uptake into the perfused rat liver and liver T4 uptake in humans are inhibited by fructose.
The American journal of physiology 1994;266(5 Pt 1):E768-75.
-
1994: Breeman W A; Hofland L J; van der Pluijm M; van Koetsveld P M; de Jong M; Setyono-Han B; Bakker W H; Kwekkeboom D J; Visser T J; Lamberts S W
A new radiolabelled somatostatin analogue [111In-DTPA-D-Phe1]RC-160: preparation, biological activity, receptor scintigraphy in rats and comparison with [111In-DTPA-D-Phe1]octreotide.
European journal of nuclear medicine 1994;21(4):328-35.
-
1994: Lim C F; Docter R; Krenning E P; van Toor H; Bernard B; de Jong M; Hennemann G
Transport of thyroxine into cultured hepatocytes: effects of mild non-thyroidal illness and calorie restriction in obese subjects.
Clinical endocrinology 1994;40(1):79-85.
-
1994: de Jong M; Docter R; Van der Hoek H; Krenning E; Van der Heide D; Quero C; Plaisier P; Vos R; Hennemann G
Different effects of amiodarone on transport of T4 and T3 into the perfused rat liver.
The American journal of physiology 1994;266(1 Pt 1):E44-9.
-
1993: Docter R; Krenning E P; de Jong M; Hennemann G
The sick euthyroid syndrome: changes in thyroid hormone serum parameters and hormone metabolism.
Clinical endocrinology 1993;39(5):499-518.
-
1993: de Jong M; Bakker W H; Breeman W A; van der Pluijm M E; Kooij P P; Visser T J; Docter R; Krenning E P
Hepatobiliary handling of iodine-125-Tyr3-octreotide and indium-111-DTPA-D-Phe1-octreotide by isolated perfused rat liver.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1993;34(11):2025-30.
-
1993: Hennemann G; Vos R A; de Jong M; Krenning E P; Docter R
Decreased peripheral 3,5,3'-triiodothyronine (T3) production from thyroxine (T4): a syndrome of impaired thyroid hormone activation due to transport inhibition of T4- into T3-producing tissues.
The Journal of clinical endocrinology and metabolism 1993;77(5):1431-5.
-
1993: Breeman W A; Hofland L J; Bakker W H; van der Pluijm M; van Koetsveld P M; de Jong M; Setyono-Han B; Kwekkeboom D J; Visser T J; Lamberts S W
Radioiodinated somatostatin analogue RC-160: preparation, biological activity, in vivo application in rats and comparison with [123I-Tyr3]octreotide.
European journal of nuclear medicine 1993;20(11):1089-94.
-
1993: Krenning E P; Kwekkeboom D J; Bakker W H; Breeman W A; Kooij P P; Oei H Y; van Hagen M; Postema P T; de Jong M; Reubi J C
Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients.
European journal of nuclear medicine 1993;20(8):716-31.
-
1993: Docter R; van Toor H; Krenning E P; de Jong M; Hennemann G
Free thyroxine assessed with three assays in sera of patients with nonthyroidal illness and of subjects with abnormal concentrations of thyroxine-binding proteins.
Clinical chemistry 1993;39(8):1668-74.
-
1993: de Jong M; Visser T J; Bernard B F; Docter R; Vos R A; Hennemann G; Krenning E P
Transport and metabolism of iodothyronines in cultured human hepatocytes.
The Journal of clinical endocrinology and metabolism 1993;77(1):139-43.
-
1993: Lim C F; Docter R; Visser T J; Krenning E P; Bernard B; van Toor H; de Jong M; Hennemann G
Inhibition of thyroxine transport into cultured rat hepatocytes by serum of nonuremic critically ill patients: effects of bilirubin and nonesterified fatty acids.
The Journal of clinical endocrinology and metabolism 1993;76(5):1165-72.
-
1993: van Stralen P G; van der Hoek H J; Docter R; de Jong M; Krenning E P; Lim C F; Hennemann G
Reduced T3 deiodination by the human hepatoblastoma cell line HepG2 caused by deficient T3 sulfation.
Biochimica et biophysica acta 1993;1157(1):114-8.
-
1993: Everts M E; Docter R; van Buuren J C; van Koetsveld P M; Hofland L J; de Jong M; Krenning E P; Hennemann G
Evidence for carrier-mediated uptake of triiodothyronine in cultured anterior pituitary cells of euthyroid rats.
Endocrinology 1993;132(3):1278-85.
-
1993: Lim C F; Bernard B F; de Jong M; Docter R; Krenning E P; Hennemann G
A furan fatty acid and indoxyl sulfate are the putative inhibitors of thyroxine hepatocyte transport in uremia.
The Journal of clinical endocrinology and metabolism 1993;76(2):318-24.
-
1992: De Jong M; Docter R; Van Der Hoek H J; Vos R A; Krenning E P; Hennemann G
Transport of 3,5,3'-triiodothyronine into the perfused rat liver and subsequent metabolism are inhibited by fasting.
Endocrinology 1992;131(1):463-70.
-
1992: Krenning E P; Bakker W H; Kooij P P; Breeman W A; Oei H Y; de Jong M; Reubi J C; Visser T J; Bruns C; Kwekkeboom D J
Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1992;33(5):652-8.
-
1991: Bakker W H; Krenning E P; Breeman W A; Kooij P P; Reubi J C; Koper J W; de Jong M; Laméris J S; Visser T J; Lamberts S W
In vivo use of a radioiodinated somatostatin analogue: dynamics, metabolism, and binding to somatostatin receptor-positive tumors in man.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1991;32(6):1184-9.
-
1991: Beetstra J B; van Engelen J G; Karels P; van der Hoek H J; de Jong M; Docter R; Krenning E P; Hennemann G; Brouwer A; Visser T J
Thyroxine and 3,3',5-triiodothyronine are glucuronidated in rat liver by different uridine diphosphate-glucuronyltransferases.
Endocrinology 1991;128(2):741-6.
-
1991: Den Toom R; De Jong M; Krenning E P; Van der Hoek H J; Ten Kate F J; Hennemann G; Terpstra O T
Euro-Collins solution versus UW-solution for long-term liver preservation in the isolated rat-liver perfusion model.
HPB surgery : a world journal of hepatic, pancreatic and biliary surgery 1991;4(4):313-20.
-
1991: Bakker W H; Krenning E P; Reubi J C; Breeman W A; Setyono-Han B; de Jong M; Kooij P P; Bruns C; van Hagen P M; Marbach P
In vivo application of [111In-DTPA-D-Phe1]-octreotide for detection of somatostatin receptor-positive tumors in rats.
Life sciences 1991;49(22):1593-601.
-
1990: Docter R; de Jong M; van der Hoek H J; Krenning E P; Hennemann G
Development and use of a mathematical two-pool model of distribution and metabolism of 3,3',5-triiodothyronine in a recirculating rat liver perfusion system: albumin does not play a role in cellular transport.
Endocrinology 1990;126(1):451-9.
Sign-in to see more
